Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Apremilast did not work for treating severe alopecia areata.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

A rare combination of halo nevi, nonsegmental vitiligo, and early gray hair can occur together.

Minoxidil, a common alopecia medication, might cause eye changes due to its properties and lack of tissue selectivity.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The woman has Discoid Lupus Erythematosus and needs specialist care.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

A 21-year-old with lichen planopilaris was successfully treated, stopping disease progression and preventing crusts.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

Using cidofovir cream for a rare skin disease can cause skin darkening.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.